APA

Kawaguchi W., Itamochi H., Kigawa J., Kanamori Y., Oishi T., Shimada M., Sato S., Shimogai R., Sato S. & Terakawa N. (20071221). Simultaneous inhibition of the mitogen-activated protein kinase kinase and phosphatidylinositol 3'-kinase pathways enhances sensitivity to paclitaxel in ovarian carcinoma. : Cancer science.

Chicago

Kawaguchi Wakae, Itamochi Hiroaki, Kigawa Junzo, Kanamori Yasunobu, Oishi Tetsuro, Shimada Muneaki, Sato Sinya, Shimogai Ruri, Sato Seiya and Terakawa Naoki. 20071221. Simultaneous inhibition of the mitogen-activated protein kinase kinase and phosphatidylinositol 3'-kinase pathways enhances sensitivity to paclitaxel in ovarian carcinoma. : Cancer science.

Harvard

Kawaguchi W., Itamochi H., Kigawa J., Kanamori Y., Oishi T., Shimada M., Sato S., Shimogai R., Sato S. and Terakawa N. (20071221). Simultaneous inhibition of the mitogen-activated protein kinase kinase and phosphatidylinositol 3'-kinase pathways enhances sensitivity to paclitaxel in ovarian carcinoma. : Cancer science.

MLA

Kawaguchi Wakae, Itamochi Hiroaki, Kigawa Junzo, Kanamori Yasunobu, Oishi Tetsuro, Shimada Muneaki, Sato Sinya, Shimogai Ruri, Sato Seiya and Terakawa Naoki. Simultaneous inhibition of the mitogen-activated protein kinase kinase and phosphatidylinositol 3'-kinase pathways enhances sensitivity to paclitaxel in ovarian carcinoma. : Cancer science. 20071221.